Med BioGene Inc.

(MBI:APH)

By |

Profile

Med Biogene Inc is a Canada based life science company. It is primarily focused on the development and commercialization of genomic-based clinical laboratory diagnostic tests. The company is engaged in managing the license and rights to GeneFx Lung, which is a proprietary gene expression-based test for identifying those patients with for early-stage non-small-cell lung cancer.

Contact Information

Website: www.medbiogene.com
Main Phone: +1 604 732-7332
Address: 598 East Kent Avenue South
State: BC
City / Town: Vancouver
Country: CAN
Postal Code: V5X 4V6

Issuer Information

Exchange: CDX
CEO: Iain Weir-Jones
Employees: 7
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)(541714)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange TSXV